PNC Financial Services Group
AMRX icon

PNC Financial Services Group’s Amneal Pharmaceuticals AMRX Stock Holding History

PNC Financial Services Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.8K Buy
3,316
+1,299
+64% +$23.4K ﹤0.01% 3210
2026
Q2 		$34.9K Buy
2,017
+285
+16% +$3.9K ﹤0.01% 3528
2026
Q1 		$21.5K Buy
1,732
+1,220
+238% +$16.4K ﹤0.01% 3662
2025
Q4 		$6.45K Buy
512
+13
+3% +$149 ﹤0.01% 4134
2025
Q3 		$5K Sell
499
-30
-6% -$269 ﹤0.01% 4204
2025
Q2 		$4.28K Buy
529
+81
+18% +$611 ﹤0.01% 4192
2025
Q1 		$3.75K Buy
448
+13
+3% +$109 ﹤0.01% 4157
2024
Q4 		$3.44K Sell
435
-37
-8% -$310 ﹤0.01% 4142
2024
Q3 		$3.93K Hold
472
– – ﹤0.01% 4109
2024
Q2 		$3K Sell
472
-32
-6% -$203 ﹤0.01% 4141
2024
Q1 		$3.05K Buy
504
+274
+119% +$1.54K ﹤0.01% 4097
2023
Q4 		$1.4K Buy
230
+97
+73% +$432 ﹤0.01% 4255
2023
Q3 		$561 Sell
133
-200
-60% -$746 ﹤0.01% 4447
2023
Q2 		$1.03K Buy
333
+133
+67% +$283 ﹤0.01% 4504
2023
Q1 		$278 Hold
200
– – ﹤0.01% 4573
2022
Q4 		$398 Hold
200
– – ﹤0.01% 4561
2022
Q3 		$0 Hold
200
– – ﹤0.01% 4433
2022
Q2 		$1K Hold
200
– – ﹤0.01% 4310
2022
Q1 		$1K Hold
200
– – ﹤0.01% 4300
2021
Q4 		$1K Buy
+200
New +$997 ﹤0.01% 4245
2020
Q4 		– Sell
-102
Closed – – 3953
2020
Q3 		$0 Hold
102
– – ﹤0.01% 3912
2020
Q2 		$0 Hold
102
– – ﹤0.01% 3899
2020
Q1 		$0 Hold
102
– – ﹤0.01% 3877
2019
Q4 		$0 Hold
102
– – ﹤0.01% 3971
2019
Q3 		$0 Sell
102
-219
-68% -$764 ﹤0.01% 3978
2019
Q2 		$2K Buy
321
+154
+92% +$1.58K ﹤0.01% 3849
2019
Q1 		$3K Buy
167
+65
+64% +$859 ﹤0.01% 3820
2018
Q4 		$2K Hold
102
– – ﹤0.01% 3836
2018
Q3 		$2K Sell
102
-247
-71% -$5.2K ﹤0.01% 3932
2018
Q2 		$6K Buy
+349
New +$6.12K ﹤0.01% 3793

Other funds holding AMRX

Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

PNC Financial Services Group's AMRX Position: Q3 2026 in Review

PNC Financial Services Group increased its Amneal Pharmaceuticals (AMRX) stake by 64% in Q3 2026, buying an estimated $23.4K and bringing the position to 3,316 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

PNC Financial Services Group first reported a position in AMRX in Q2 2018 and has held it in 30 quarters since. 252 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • PNC Financial Services Group held 3,316 shares of Amneal Pharmaceuticals worth $66.8K as of Q3 2026.
  • PNC Financial Services Group bought 1,299 Amneal Pharmaceuticals shares in Q3 2026, an estimated $23.4K.
  • Amneal Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3210 holding.
  • PNC Financial Services Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 30 quarters since.
  • 252 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.